| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
2
2
2
2
2
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
D
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 1.1 | 0.0 | 1.1 |
| Stocks | 0.35 | 0.0 | 0.35 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.78 | 0.0 | 0.78 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 97.77 | 0.0 | 97.77 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 01.31.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 01.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Novartis AG | NVSEF | 14.18 | 2.36 |
| Sanofi | SAN | --- | 2.3 |
| Eni SpA | ENI | --- | 1.89 |
| HSBC Holdings PLC | HBCYF | 7.93 | 1.85 |
| Nestle SA | NSRGF | 0.68 | 1.71 |
| Astellas Pharma, Inc. | 4503 | --- | 1.49 |
| BG Group PLC | BG. | --- | 1.45 |
| Total SA | FP | --- | 1.34 |
| Canon, Inc. | CAJFF | -15.14 | 1.22 |
| Roche Holding AG | RHHVF | 21.67 | 1.2 |
